To help combat the novel coronavirus pandemic in the country, specialty chemicals company Lanxess donated six ventilators worth over Rs 1 crore to Kaushalya Medical Foundation Trust Hospital and Bethany Hospital in Thane. Both hospitals have been provided with three ventilators each. The donation was made as part of the company’s CSR initiative for 2020-2021.
The hospitals located in Thane will use these ventilators for the treatment of patients from neighboring areas. Lanxess has been proactively collaborating with authorities and medical institutions in its concerted efforts to help the local community in fighting the pandemic.
In the past months, Lanxess India has undertaken various initiatives to minimize the impact of Covid-19. This includes financial support of Rs 2 crore to the Prime Minister’s Citizen Assistance and Relief in Emergency Situations Fund (PM CARES) and donation of relief material worth Rs 30 lakhs to local authorities in the states of Maharashtra, Madhya Pradesh, and Gujarat. This also included collaboration with the Akshaya Patra Foundation, through which the company provided over 30,000 free meals to the needy.
Lanxess helped reduce coronavirus cross-contamination by donating 1 ton of its surface disinfectant, Rely+On Virkon, to the BMC and TMC through the Government of Maharashtra relief co-ordination center.
Sameep Sohoni, consultant orthopedic and joint replacement surgeon, Kaushalya Medical Foundation Trust Hospital said, “We are grateful to Lanxess India for donating these ventilators to us as it is the most important equipment which is required in the management of Covid patients in ICU and who have low oxygen levels. We thank the management of Lanxess India for this support and are sure that this donation would help us save more lives and will also give a moral boost to our team that has been working tirelessly for Covid patients for the past 5 months.”
Thanking Lanxess for its support, Vijay Lakka, chief operating officer, Bethany Hospital, said, “ Lanxess India’s donation of these high-end ventilators at this juncture enables our hospital to try save more lives, especially when there is a huge shortage globally for critical-care equipment. These specific ventilators equipped with High-flow nasal oxygen (HFNO) therapy can provide respiratory support for patients with acute hypoxemic respiratory failure and can also prevent subsequent intubation in this pandemic situation. Thank you for being part of our community and stepping up to do what very few have accomplished in these difficult times.”
Neelanjan Banerjee, vice chairman, and managing director, Lanxess India, commented, “In these challenging times, medical institutions and their infrastructure have witnessed tremendous stress. Having identified this as a critical area that needs immediate attention, we have made a humble attempt in easing out the pressure. Our contribution is specially aimed at making critical care available and enhancing life-saving infrastructure in these hospitals. We are hoping to make a significant difference in our society and will continue to help the community at large in fighting the pandemic.”
